Categories
Delhi News

CIPLA | Earnings prospects improve on both domestic and US business front | Stock Of The Day



Cipla is amongst the leading pharmaceuticals having a significant presence in two key markets – Indian and the US. It is chiefly known for respiratory therapies due which its products were is in demand during COVID pandemic. It commands a sizeable share in chronic therapies, with a presence in cardiovascular, diabetic and respiratory therapies.
#stocks #cipla #stockmarket

Moneycontrol is India’s leading financial and business portal with in-depth market coverage, analysis, expert opinions, and a gamut of financial tools.
A part of Network18, moneycontrol.com is the most influential destination for stock market news and advice, business news, and news about the Indian and global economy.
Subscribe:
Follow us:
Visit
Facebook:
Twitter:
Instagram:

source

Contact Us for Insurance Needs in Rohini, Delhi, Pitampura

We are a group of best insurance advisors in Delhi. We are experts in LIC and have received number of awards.
If you are near Delhi or Rohini or Pitampura Contact Us Here

Leave a Reply

Your email address will not be published. Required fields are marked *